Research Article
Co-encapsulation of β-D-Galactosidase and Ascorbic Acid in the Milk Protein-Based Microcapsules: Optimization and Characterization
Table 2
Optimum microencapsulation conditions of βg/VC stabilized by WPI and SC.
| Factor name | Goal | Optimized value | | Desirability (%) | | Microcapsule I | Microcapsule II | Microcapsule I | Microcapsule II |
| A: WPI | In range | 0 | 0.2 | 100 | 100 | B: SC | In range | 1 | 0.8 | 100 | 100 | C: core/coating ratio (%) | In range | 100 | 100 | 100 | 100 | D: US power (W) | In range | 79.4 | 75 | 100 | 100 | Particle size (nm) | Minimize | 479.98 | 501.7 | 59 | 56.21 | PDI | Minimize | 0.185 | 0.185 | 100 | 100 | Zeta potential (mV) | Maximize | 11.18 | 9.66 | 88.99 | 82.31 | EE (lactase enzyme) (%) | Maximize | 94.87 | 94.87 | 93.76 | 93.76 | EE (ascorbic acid) (%) | Maximize | 91.13 | 90.91 | 94.67 | 93.95 | Lactase activity (%) | Maximize | 55.21 | 51.62 | 83.47 | 77.93 | Viscosity (mPa·s) | None | 16 | 34.73 | 100 | 100 |
|
|